What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...
Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...
Endometrial cancer treatments can save your life, but they can also cause some unpleasant side effects. Everyone reacts to cancer treatment differently, and the side effects you experience may be ...
—In this study, molecular classification of endometrial cancer with cervical stromal invasion was associated with recurrence-free survival by univariate analysis. But after controlling for tumor stage ...
Endometrial cancer is one of the most common forms of cancer in women. It begins in the lining of the uterus and surgery usually offers the best chance for survival. Doctors at UNC Hospitals have ...
A combination of Verzenio and letrozole has shown encouraging and lasting responses in patients with advanced or recurrent endometrial cancer, according to findings presented by Dr. Marilyn Huang, at ...
Women with presumed uterine growths known as fibroids who underwent laparoscopic power morcellation (LPM) have higher rates of uterine cancer recurrence and worse outcomes compared to those who got ...
Retrospective analysis of ctDNA results from real-world data was performed for 61 patients (233 plasma time points) diagnosed with early-stage UC. ctDNA status and dynamics were assessed using a ...
The new test removes the need for patients to have to undergo physical examinations, scans and biopsies to see if cancer has ...
MedPage Today on MSNOpinion
Call to integrate obesity management with surgery, GLP-1s into cancer care
"Most effective therapies" underutilized, say authors, but oncologist cites lack of qualit ...
PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab
The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results